These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Shetti CN; Reddy YC; Kandavel T; Kashyap K; Singisetti S; Hiremath AS; Siddequehusen MU; Raghunandanan S J Clin Psychiatry; 2005 Dec; 66(12):1517-23. PubMed ID: 16401151 [TBL] [Abstract][Full Text] [Related]
9. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study. Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971 [TBL] [Abstract][Full Text] [Related]
10. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. Dell'Osso B; Nestadt G; Allen A; Hollander E J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725 [TBL] [Abstract][Full Text] [Related]
11. OCD: where the serotonin selectivity story begins. Pigott TA J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]
13. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Shanahan NA; Velez LP; Masten VL; Dulawa SC Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503 [TBL] [Abstract][Full Text] [Related]
14. A review of pharmacologic treatments for obsessive-compulsive disorder. Kaplan A; Hollander E Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138 [TBL] [Abstract][Full Text] [Related]